Key points are not available for this paper at this time.
mice also had reduced airway remodeling in experimental chronic asthma and pulmonary fibrosis. Our data show that Fbln1c may be a therapeutic target in chronic respiratory diseases.
Liu et al. (Wed,) studied this question.